ADTX vs AIMD

For growth investors, Aditxt, Inc.

(ADTX) is the stronger pick with -79. 2% revenue growth year-over-year, versus -83. 0% for Ainos, Inc. (AIMD). The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Ainos, Inc.

(AIMD) delivered a total return of -99. 4%, compared to -100. 0% for Aditxt, Inc. (ADTX). Over 10 years, the gap is even starker: AIMD returned -97. 0% versus ADTX's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Aditxt, Inc.

(ADTX) is the lower-risk stock at 1. 71β versus Ainos, Inc. 's 2. 54β — meaning AIMD is approximately 49% more volatile than ADTX relative to the S&P 500. On balance sheet safety, Ainos, Inc. (AIMD) carries a lower debt/equity ratio of 77% versus 84% for Aditxt, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Aditxt, Inc.

(ADTX) is pulling ahead at -79. 2% versus -83. 0% for Ainos, Inc. (AIMD). On earnings-per-share growth, the picture is similar: Ainos, Inc. grew EPS 53. 6% year-over-year, compared to -38. 6% for Aditxt, Inc.. Over a 3-year CAGR, ADTX leads at 8. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Aditxt, Inc.

(ADTX) is the more profitable company, earning -257. 1% net margin versus -717. 0% for Ainos, Inc. — meaning it keeps -257. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ADTX leads at -208. 0% versus -667. 7% for AIMD. At the gross margin level — before operating expenses — AIMD leads at -153. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Aditxt, Inc.

(ADTX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Ainos, Inc. (AIMD) carries a higher beta of 2. 54 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ADTX: -100. 0%, AIMD: -97. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.